COYA Coya Therapeutics, Inc.
$4.38▼ -3.10%
Healthcare
Other
After hours
$4.38▲ +0.00%
Sep 11, 7:30 PM ET
Volume 139.3K
Avg Volume (10D) 88.6K
Key Metrics & Fundamentals
Market Cap
$102.75M
P/E Ratio
–
Div Yield
–%
52W Range
3.71 - 7.75
% vs 50 MA
-6.97%
% vs 200 MA
-9.35%
RSI-14
40.8
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.43
Free Cash Flow
-$8.26M
Gross Rev
$243,745
Gross Profit
$243,745
EBITDA
-$7.04M
COGS
–
Operating Exp
$7.29M
Operating Income
-$7.05M
EBIT
-$7.05M
Pretax Income
-$6.64M
Net Income
-$6.64M
EPS (Diluted)
-0.28
Price & Volume History
Loading chart…
Recent News
Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Established Model of Peripheral and CNS Inflammation
Business Wire · Sep 8, 2026 12:00 PM
Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Business Wire · Aug 11, 2026 12:00 PM
Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year?
Zacks · Jun 30, 2026 1:40 PM
Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting
Business Wire · Jun 18, 2026 12:00 PM
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
Business Wire · Jun 15, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See COYA's money flow as a full page
Social Sentiment
No Reddit posts found for COYA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.